Anne Beaven - Concepedia

Author

Anne Beaven

Also Known As

A Beaven, A. Beaven, A. W. Beaven, A., Beaven, A.W. Beaven, ANNE W. BEAVEN, Anne Beaven, Anne W Beaven, Anne W. Beaven, Beaven, A.W.

179

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Duke Medical Center University of North Carolina at Chapel Hill Duke University UNC Lineberger Comprehensive Cancer Center Washington University in St. Louis

About

Anne Beaven is an author at Duke Medical Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	17	733
2	Health Sciences	10	10	259
3	Immunology	10	11	554
4	Cellular Therapies	5	5	120
5	Global Health	1	1	12

Anne Beaven

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma Carlos A. Ramos, Natalie S. Grover, Anne Beaven, Journal of Clinical Oncology	2020	366
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study John F. Seymour, Shuo Ma, Danielle M. Brander, The Lancet Oncology Phase 1BLymphoid NeoplasiaHematological MalignancyMedicineImmunology	2017	321
The Genetic Basis of Hepatosplenic T-cell Lymphoma Matthew McKinney, Andrea B. Moffitt, Philippe Gaulard, Cancer Discovery	2017	195
Randomized Phase III Study of Alisertib or Investigator’s Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma Owen A. O’Connor, Muhıt Özcan, Eric D. Jacobsen, Journal of Clinical Oncology	2019	143
A phase <scp>II</scp> study of cyclophosphamide, etoposide, vincristine and prednisone ( <scp>CEOP</scp> ) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T‐cell lymphoma ( <scp>PTCL</scp> ): final results from the T‐ cell consortium trial Ranjana H. Advani, Stephen M. Ansell, Mary Jo Lechowicz, British Journal of Haematology	2015	87
Impact of Consolidation Radiation Therapy in Stage III-IV Diffuse Large B-cell Lymphoma With Negative Post-Chemotherapy Radiologic Imaging Jennifer A. Dorth, Leonard R. Prosnitz, Gloria Broadwater, International Journal of Radiation OncologyBiologyPhysics Lymphoid NeoplasiaOncologyOncologic ImagingRadiation TherapyMedicine	2012	76
Addition of lenalidomide to rituximab, ifosfamide, carboplatin, etoposide (<scp>RICER</scp>) in first‐relapse/primary refractory diffuse large B‐cell lymphoma Tatyana Feldman, Anthony R. Mato, Kar Fai Chow, British Journal of Haematology	2014	51
Belinostat in combination with standard cyclophosphamide, doxorubicin, vincristine and prednisone as first-line treatment for patients with newly diagnosed peripheral T-cell lymphoma Patrick B. Johnston, Amanda F. Cashen, Petros Nikolinakos, Experimental Hematology and Oncology	2021	51
PAK1 Mediates Resistance to PI3K Inhibition in Lymphomas Katherine Walsh, Matthew McKinney, Cassandra Love, Clinical Cancer Research	2013	50
A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory B-Cell Lymphoma Joseph M. Tuscano, Emanual Maverakis, Susan Groshen, Clinical Cancer Research	2019	47

Page 1